Transcatheter treatment of pure aortic regurgitation,Nature Reviews Cardiology

当前位置： X-MOL 学术 › Nat. Rev. Cardiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Transcatheter treatment of pure aortic regurgitation
Nature Reviews Cardiology ( IF 41.7 ) Pub Date : 2024-06-27 , DOI: 10.1038/s41569-024-01059-1
Marco Barbanti ₁ , Giulia Laterra ₁ , Francesco Maisano ₂

Affiliation

Preliminary experience with the use of transcatheter aortic valve implantation (TAVI) to treat non-calcific aortic regurgitation has raised concerns about the short-term effectiveness of TAVI in this setting. A deeper understanding of the interaction between transcatheter heart valves and anatomy in patients with non-calcific aortic valve disease, coupled with the introduction of dedicated TAVI devices, is providing new opportunities in the management of this condition.

中文翻译：

单纯主动脉瓣关闭不全的经导管治疗

使用经导管主动脉瓣植入术 (TAVI) 治疗非钙化性主动脉瓣反流的初步经验引起了人们对 TAVI 在这种情况下的短期有效性的担忧。对非钙化性主动脉瓣疾病患者经导管心脏瓣膜与解剖结构之间相互作用的更深入了解，加上专用 TAVI 设备的引入，为治疗这种疾病提供了新的机会。

更新日期：2024-06-27

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南